Maxine Gowen

Maxine Gowen has served as a member of Aclaris’ board of directors since July 2019. Dr. Gowen joined TamuroBio Inc., a biotechnology company, in August 2019, and currently serves as its part-time Chief Executive Officer. Prior to joining TamuroBio, Dr. Gowen founded Trevena, Inc., a publicly held biopharmaceutical company, and served as its President and Chief Executive Officer from 2007 until October 2018. Prior to this, Dr. Gowen held a variety of leadership roles at GlaxoSmithKline (GSK) over a period of fifteen years. As Senior Vice President for the Center of Excellence for External Drug Discovery (CEEDD), she developed an innovative new approach to externalizing drug discovery in big pharma. Dr. Gowen was previously President and Managing Partner at SR One, the venture capital subsidiary of GSK, where she led its investments in, and served on the board of directors of, numerous companies. Until 2002, Dr. Gowen was Vice President, Drug Discovery, Musculoskeletal Diseases at GSK, responsible for drug discovery and early development for osteoporosis, arthritis, and metastatic bone disease. Dr. Gowen held a tenured academic position in the School of Pharmacology, University of Bath, the UK from 1989 to 1992. Dr. Gowen currently serves on the boards of directors of the publicly held companies of Idera Pharmaceuticals, Inc., Merus N.V., and Passage Bio, Inc. She also currently serves on the board of directors of Life Sciences Pennsylvania, an industry association. Dr. Gowen served on the board of the national biotechnology industry association, BIO, from 2008 to 2018, and within the past five years served on the boards of directors of the publicly held companies Trevena, Inc. and Akebia Therapeutics, Inc. Dr. Gowen received a Bachelor of Science in biochemistry from the University of Bristol, UK then received a Doctor of Philosophy in cell biology from the University of Sheffield, UK, and received a Master of Business Administration from The Wharton School of the University of Pennsylvania. Dr. Gowen also received a Doctor of Science from the University of Bath, UK.